Scaffdex Oy and Conmed Linvatec Biomaterials Sign a Licensing Agreement of Commercialization and Clinical Data of Joint Prosthesis Innovation
News Sep 15, 2009
Scaffdex Oy and Conmed Linvatec Biomaterials have signed a licensing agreement of commercialization and clinical data of joint prosthesis innovation. Target of Scaffdex Oy is CE marking and launch of this product by end of 2010.
Joint prosthesis replaces small joints in hand and foot and it has been tested clinically for example in rheumatoid arthritis patients. Tampere University Hospital, Hospital of Foundation of Rheumatoid Arthritis in Heinola and clinics in Germany and Italy participated these international clinical trials.